Matthew Felwick

Matthew focusses on product liability and commercial disputes in the pharmaceutical, biotech and medical devices industries. He is also experienced in the manufacturing, oil and gas, tobacco and consumer goods sectors. Matthew helped one of the world's leading pharmaceutical companies defend product liability claims and navigate a regulatory investigation following the voluntary withdrawal of a blockbuster product and he defended a global manufacturer to claims across a number of jurisdictions following the supply of products to customers in the life sciences sector. He is currently advising a biotech client on a claim against a CRO regarding the conduct of a large-scale multi-centre Phase III clinical trial.

Matthew has specialist experience required to defend clients from collective actions, having acted in a number of high profile Group Actions in the High Court relating to Vioxx, Blood Products, All Metal Hips and Niger Delta Oil Spills. He regularly gives litigation and risk management advice to global companies including in respect of coronial inquests, regulatory investigations and prosecutions and crisis management.

Matthew is described as 'a rising star' who 'combines sharp intelligence with a strong commercial awareness' by Legal 500 2017 where he is recognised for both Product Liability: defendant and Pharmaceuticals and Biotechnology. Matthew is also recognised as one of the leading product lawyers in the UK by Who's Who Legal: Product Liability Defence 2017.